Representative Lisa C. McClain (R-Michigan) recently sold shares of Novanta Inc. NASDAQ: NOVT. In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Novanta stock on August 4th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
- Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
- Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
- Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
- Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.
Novanta Trading Down 2.2%
NOVT traded down $2.53 during midday trading on Friday, hitting $114.69. The company's stock had a trading volume of 663,741 shares, compared to its average volume of 319,410. The company has a current ratio of 2.54, a quick ratio of 1.62 and a debt-to-equity ratio of 0.57. The firm has a market cap of $4.13 billion, a P/E ratio of 67.47 and a beta of 1.50. The firm has a 50-day moving average price of $118.95 and a two-hundred day moving average price of $123.09. Novanta Inc. has a 52-week low of $98.76 and a 52-week high of $184.11.
Novanta (NASDAQ:NOVT - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The technology company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.74 by $0.02. The company had revenue of $241.05 million during the quarter, compared to analysts' expectations of $237.97 million. Novanta had a return on equity of 14.70% and a net margin of 6.41%.The firm's revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.73 EPS. Novanta has set its FY 2025 guidance at 3.220-3.360 EPS. Q3 2025 guidance at 0.780-0.850 EPS. On average, research analysts anticipate that Novanta Inc. will post 3.03 earnings per share for the current year.
Novanta announced that its board has approved a stock repurchase plan on Thursday, September 18th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the technology company to reacquire up to 4.9% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.
Hedge Funds Weigh In On Novanta
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank acquired a new position in shares of Novanta in the 2nd quarter valued at approximately $29,982,000. Brown Advisory Inc. raised its position in shares of Novanta by 8,526.6% in the 2nd quarter. Brown Advisory Inc. now owns 220,409 shares of the technology company's stock valued at $28,417,000 after purchasing an additional 217,854 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in shares of Novanta by 15.7% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,579,626 shares of the technology company's stock valued at $203,661,000 after purchasing an additional 214,374 shares in the last quarter. Bamco Inc. NY raised its position in shares of Novanta by 202.3% in the 2nd quarter. Bamco Inc. NY now owns 311,115 shares of the technology company's stock valued at $40,112,000 after purchasing an additional 208,188 shares in the last quarter. Finally, Champlain Investment Partners LLC raised its position in shares of Novanta by 45.6% in the 1st quarter. Champlain Investment Partners LLC now owns 596,190 shares of the technology company's stock valued at $76,235,000 after purchasing an additional 186,848 shares in the last quarter. 98.35% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Wall Street Zen cut Novanta from a "buy" rating to a "hold" rating in a report on Monday, August 11th. Robert W. Baird decreased their target price on Novanta from $139.00 to $133.00 and set a "neutral" rating for the company in a report on Monday, August 11th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $133.00.
Check Out Our Latest Research Report on Novanta
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Novanta Company Profile
(
Get Free Report)
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Recommended Stories
Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.